1. Thyroid transcription factor 1 expression is associated with outcome of patients with non-squamous non-small cell lung cancer treated with pemetrexed-based chemotherapy
   Ondrej Fiala et al, 2017, Tumor Biology CrossRef
2. Leptin induces epithelial-to-mesenchymal transition via activation of the ERK signaling pathway in lung cancer cells
   Min Xu et al, 2018, Oncology Letters CrossRef
3. High lymphocyte population-related predictive factors for a long-term response in non-small cell lung cancer patients treated with pemetrexed: a retrospective observational study
   Issei Sumiyoshi et al, 2021, Journal of Translational Medicine CrossRef
4. Predictive factors for a long-term response duration in non-squamous cell lung cancer patients treated with pemetrexed
   Sojung Park et al, 2016, BMC Cancer CrossRef
5. Serum and tissue leptin in lung cancer: A meta-analysis
   Xiang Tong et al, 2017, Oncotarget CrossRef
6. The role of pemetrexed in recurrent epithelial ovarian cancer: A scoping review
   Michael Roche et al, 2018, Oncology Reviews CrossRef